A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)

NCT07219550 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatic Impairment

Interventions

DRUG: Calderasib

Sponsor

Merck Sharp & Dohme LLC